Pidaran Murugan

997 total citations
21 papers, 822 citations indexed

About

Pidaran Murugan is a scholar working on Molecular Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Pidaran Murugan has authored 21 papers receiving a total of 822 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Medicine, 13 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Molecular Biology. Recurrent topics in Pidaran Murugan's work include Curcumin's Biomedical Applications (14 papers), Natural Antidiabetic Agents Studies (11 papers) and Advanced Glycation End Products research (5 papers). Pidaran Murugan is often cited by papers focused on Curcumin's Biomedical Applications (14 papers), Natural Antidiabetic Agents Studies (11 papers) and Advanced Glycation End Products research (5 papers). Pidaran Murugan collaborates with scholars based in India. Pidaran Murugan's co-authors include Leelavinothan Pari, Chippada Appa Rao and Meivelu Moovendhan‬‬‬‬‬‬‬‬ and has published in prestigious journals such as Journal of Ethnopharmacology, Life Sciences and Plant Foods for Human Nutrition.

In The Last Decade

Pidaran Murugan

21 papers receiving 747 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pidaran Murugan India 13 478 349 251 152 117 21 822
Danja J. Den Hartogh Canada 11 138 0.3× 146 0.4× 276 1.1× 133 0.9× 73 0.6× 11 704
Luis Baró Spain 14 174 0.4× 88 0.3× 211 0.8× 151 1.0× 70 0.6× 22 912
Hye‐Jin Kim South Korea 6 162 0.3× 134 0.4× 117 0.5× 148 1.0× 29 0.2× 9 506
Syeda T. Hasan United States 5 195 0.4× 93 0.3× 222 0.9× 165 1.1× 48 0.4× 6 683
Carlos Alberto Arcaro Brazil 10 141 0.3× 126 0.4× 131 0.5× 70 0.5× 45 0.4× 13 437
Sreejayan Nair United States 6 178 0.4× 76 0.2× 187 0.7× 59 0.4× 60 0.5× 7 654
Vânia Ortega Gutierres Brazil 8 157 0.3× 131 0.4× 100 0.4× 64 0.4× 39 0.3× 10 374
Zhiwen Yu China 7 147 0.3× 100 0.3× 230 0.9× 152 1.0× 24 0.2× 7 510
Jia‐Ching Wu Taiwan 15 122 0.3× 75 0.2× 397 1.6× 157 1.0× 89 0.8× 19 844
M.V. Venkataranganna India 16 76 0.2× 208 0.6× 234 0.9× 52 0.3× 87 0.7× 42 811

Countries citing papers authored by Pidaran Murugan

Since Specialization
Citations

This map shows the geographic impact of Pidaran Murugan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pidaran Murugan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pidaran Murugan more than expected).

Fields of papers citing papers by Pidaran Murugan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pidaran Murugan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pidaran Murugan. The network helps show where Pidaran Murugan may publish in the future.

Co-authorship network of co-authors of Pidaran Murugan

This figure shows the co-authorship network connecting the top 25 collaborators of Pidaran Murugan. A scholar is included among the top collaborators of Pidaran Murugan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pidaran Murugan. Pidaran Murugan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murugan, Pidaran, et al.. (2025). Brazilin-enriched Caesalpinia sappan heartwood extract mitigates Doxorubicin-induced cardiotoxicity. Pharmacological Research - Modern Chinese Medicine. 16. 100667–100667. 2 indexed citations
3.
Murugan, Pidaran. (2023). Effects of Cassia auriculata Flower Buds Extract on Some Blood and Tissue Parameters in Streptozotocin-Nicotinamide Induced Diabetic Rats. International Journal of Zoological Investigations. 9(2). 738–746. 1 indexed citations
4.
Murugan, Pidaran, et al.. (2023). Effect of Tetrahydrocurcumin Compared to Curcumin in Carbohydrate Metabolism and Glycoprotein Components in Type 2 Diabetes - Systematic Review. Journal Of Advanced Zoology. 44(S7). 157–167. 1 indexed citations
5.
6.
Murugan, Pidaran, Leelavinothan Pari, & Chippada Appa Rao. (2008). Effect of tetrahydrocurcumin on insulin receptor status in type 2 diabetic rats: studies on insulin binding to erythrocytes. Journal of Biosciences. 33(1). 63–72. 31 indexed citations
7.
Pari, Leelavinothan, Pidaran Murugan, & Chippada Appa Rao. (2007). Influence of Cassia auriculata flowers on insulin receptors in streptozotocin induced diabetic rats: studies on insulin binding to erythrocytes. African Journal of Biochemistry Research. 1(7). 148–155. 4 indexed citations
8.
Pari, Leelavinothan & Pidaran Murugan. (2007). Tetrahydrocurcumin Prevents Brain Lipid Peroxidation in Streptozotocin-Induced Diabetic Rats. Journal of Medicinal Food. 10(2). 323–329. 53 indexed citations
9.
Murugan, Pidaran & Leelavinothan Pari. (2007). Influence of tetrahydrocurcumin on erythrocyte membrane bound enzymes and antioxidant status in experimental type 2 diabetic rats. Journal of Ethnopharmacology. 113(3). 479–486. 67 indexed citations
10.
Pari, Leelavinothan & Pidaran Murugan. (2007). Antihyperlipidemic Effect of Curcumin and Tetrahydrocurcumin in Experimental Type 2 Diabetic Rats. Renal Failure. 29(7). 881–889. 94 indexed citations
11.
Pari, Leelavinothan & Pidaran Murugan. (2007). Influence of tetrahydrocurcumin on tail tendon collagen contents and its properties in rats with streptozotocin–nicotinamide‐induced type 2 diabetes. Fundamental and Clinical Pharmacology. 21(6). 665–671. 26 indexed citations
12.
Pari, Leelavinothan & Pidaran Murugan. (2007). Changes in Glycoprotein Components in Streptozotocin - Nicotinamide Induced Type 2 Diabetes: Influence of Tetrahydrocurcumin from Curcuma longa. Plant Foods for Human Nutrition. 62(1). 25–29. 49 indexed citations
13.
Murugan, Pidaran & Leelavinothan Pari. (2007). Influence of Tetrahydrocurcumin on Hepatic and Renal Functional Markers and Protein Levels in Experimental Type 2 Diabetic Rats. Basic & Clinical Pharmacology & Toxicology. 101(4). 241–245. 73 indexed citations
14.
Murugan, Pidaran & Leelavinothan Pari. (2007). Protective role of tetrahydrocurcumin on changes in the fatty acid composition in streptozotocin-nicotinamide induced type 2 diabetic rats. Journal of Applied Biomedicine. 5(1). 31–38. 17 indexed citations
15.
Murugan, Pidaran & Leelavinothan Pari. (2006). Effect of Tetrahydrocurcumin on Lipid Peroxidation and Lipids in Streptozotocin‐Nicotinamide‐Induced Diabetic Rats. Basic & Clinical Pharmacology & Toxicology. 99(2). 122–127. 55 indexed citations
16.
Pari, Leelavinothan & Pidaran Murugan. (2006). Tetrahydrocurcumin: Effect on Chloroquine‐Mediated Oxidative Damage in Rat Kidney. Basic & Clinical Pharmacology & Toxicology. 99(5). 329–334. 39 indexed citations
17.
Murugan, Pidaran & Leelavinothan Pari. (2006). Effect of Tetrahydrocurcumin on Plasma Antioxidants in Streptozotocin-Nicotinamide Induced Experimental Diabetes. Journal of Basic and Clinical Physiology and Pharmacology. 17(4). 231–244. 27 indexed citations
18.
Murugan, Pidaran & Leelavinothan Pari. (2006). Antioxidant effect of tetrahydrocurcumin in streptozotocin–nicotinamide induced diabetic rats. Life Sciences. 79(18). 1720–1728. 163 indexed citations
19.
Murugan, Pidaran & Leelavinothan Pari. (2005). EFFECT OF TETRAHYDROCURCUMIN ON ERYTHROMYCIN ESTOLATE-INDUCED LIPID PEROXIDATION IN RATS. Journal of Basic and Clinical Physiology and Pharmacology. 16(1). 1–16. 10 indexed citations
20.
Pari, Leelavinothan & Pidaran Murugan. (2005). EFFECT OF TETRAHYDROCURCUMIN ON BLOOD GLUCOSE, PLASMA INSULIN AND HEPATIC KEY ENZYMES IN STREPTOZOTOCIN INDUCED DIABETIC RATS. Journal of Basic and Clinical Physiology and Pharmacology. 16(4). 257–274. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026